[Federal Register Volume 84, Number 80 (Thursday, April 25, 2019)]
[Notices]
[Page 17416]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-08312]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Sickle Cell Disease 
Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Sickle Cell Disease Advisory Committee.
    Date: May 31, 2019.
    Time: 8:30 a.m. to 2:30 p.m.
    Agenda: Discussion of Programs.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892.
    Contact Person: W. Keith Hoots, MD, Director, Division of Blood 
Diseases and Resources, National Heart, Lung, and Blood Institute, 
National Institutes of Health, 6701 Rockledge Drive, Suite 9030, 
Bethesda, MD 20892, 301-435-0080, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: April 19, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-08312 Filed 4-24-19; 8:45 am]
BILLING CODE 4140-01-P